Schneider, Jennifer L.
Firemark, Alison J.
Gille, Sara
Davis, James
Pawloski, Pamala A.
Liang, Su-Ying
Epstein, Mara M.
Lowery, Jan
Lu, Christine Y.
Sharaf, Ravi N.
Burnett-Hartman, Andrea N.
Schlieder, Victoria
Salvati, Zachary M.
Cragun, Deborah
Rahm, Alanna Kulchak
Hunter, Jessica Ezzell
Funding for this research was provided by:
National Cancer Institute (1RO1CA211723, 1RO1CA211723, 1RO1CA211723, 1RO1CA211723, 1RO1CA211723, 1RO1CA211723, 1RO1CA211723, 1RO1CA211723, 1RO1CA211723, 1RO1CA211723, 1RO1CA211723, 1RO1CA211723, 1RO1CA211723, 1RO1CA211723, 1RO1CA211723, 1RO1CA211723)
Article History
Received: 30 June 2023
Accepted: 13 November 2023
First Online: 17 November 2023
Declarations
:
: This research was performed in accordance with relevant guidelines and regulations (such as the Declaration of Helsinki). All study procedures for the interviews were approved by primary site Institutional Review Board (Geisinger: 2017 − 0238), and the Sutter Health IRB (for Palo Alto Medical Foundation Research Institute, 2017.134EXP). All other participating sites elected to cede IRB oversight to Geisinger IRB. Informed consent for interview participants was obtained verbally as part of the interview process. Participants received a study information sheet upon invitation to participate and all elements of consent were reviewed prior to commencing interview and following informed consent guidelines.
: Not applicable.
: The authors declare no competing interests.